Drawing for ENA

USPTO serial 79251923

ENA

Reviewed by CopyMark Law Group

Reg. 5952326Status 709
Filing date
Status date
Registration date
Jan 7, 2020
Examiner
VALLILLO, MELISSA C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ENA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark Lebow

Mark Lebow Ladas & Parry1700 Diagonal RoadSuite 505Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
005Nucleic acid medicines for use in the treatment and prevention of genetic disorders; synthetic biomolecules, namely, synthetic nucleoside, synthetic nucleotide and synthetic nucleic acid for clinical or medical use in the treatment and prevention of genetic disordersSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 24, 2026C71TCANCELLED SECTION 71—
Apr 2, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 7, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 3, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 8, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 18, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 18, 2020FIMPFINAL DISPOSITION PROCESSED—
Apr 7, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 7, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 22, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 22, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 19, 2019GPNXNOTIFICATION PROCESSED BY IB—
Oct 2, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 2, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 2, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 18, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 17, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 17, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2019RFNTREFUSAL PROCESSED BY IB—
Mar 18, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 18, 2019RFRRREFUSAL PROCESSED BY MPU—
Mar 8, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 7, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 6, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2019DOCKASSIGNED TO EXAMINER—
Mar 4, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 15, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 14, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance